Rockwell Medical updates corporate presentation
Rockwell Medical, Inc. furnished an updated corporate presentation, dated May 7, 2026, for investor and public reference.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Rockwell Medical, Inc. furnished an updated corporate presentation, dated May 7, 2026, for investor and public reference. The presentation is provided as Exhibit 99.1 under a current report. The material is furnished under Regulation FD, meaning it is not treated as filed for liability purposes.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Terms
Regulation FD, Section 18 of the Securities Exchange Act of 1934, Inline XBRL
3 terms
Regulation FD regulatory
"Item 7.01 Regulation FD Disclosure. On May 7, 2026, Rockwell Medical, Inc. made available an updated corporate presentation."
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
Section 18 of the Securities Exchange Act of 1934 regulatory
"shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended"
Inline XBRL technical
"104 | Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101."
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Rockwell Medical (RMTI) disclose in this May 7, 2026 report?
Rockwell Medical furnished an updated corporate presentation dated May 7, 2026 as part of a current report. The presentation, attached as Exhibit 99.1, provides updated corporate information but is furnished under Regulation FD rather than formally filed for liability purposes.
How is the Rockwell Medical (RMTI) corporate presentation provided to investors?
The corporate presentation is attached as Exhibit 99.1 to the report. Rockwell Medical states it has made the updated presentation available and furnished it as an exhibit, allowing investors and the public to review the latest corporate information directly from the accompanying materials.
Does the Rockwell Medical (RMTI) presentation count as filed financial information?
No. Rockwell Medical specifies the information in the report, including Exhibit 99.1, is furnished under Regulation FD and not deemed filed under Section 18 of the Exchange Act. This limits associated liability compared with information formally designated as filed.
Who signed the Rockwell Medical (RMTI) current report containing the presentation?
The report was signed on behalf of Rockwell Medical by Chief Executive Officer Mark Strobeck. His signature indicates the company’s authorization of the furnished disclosure, including the updated corporate presentation attached as Exhibit 99.1 to the current report.
What additional exhibits accompany Rockwell Medical’s (RMTI) corporate presentation?
Two exhibits accompany the report: Exhibit 99.1 is Rockwell Medical’s corporate presentation dated May 7, 2026, and Exhibit 104 is the cover page interactive data file. The interactive data is formatted in Inline XBRL and included as Exhibit 101-related content.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices, including zip code)
(248 ) 960-9009
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) | ||||||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol | Name of Each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On May 7, 2026, Rockwell Medical, Inc. made available an updated corporate presentation. A copy of the corporate presentation is furnished herewith as Exhibit 99.1 and incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits The following exhibit is being furnished herewith:
EXHIBIT INDEX
| Exhibit No. | Description | |||||||
| 99.1 | Rockwell Medical, Inc. Corporate Presentation, dated May 7, 2026 | |||||||
| 104 | Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101. | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ROCKWELL MEDICAL, INC. | ||||||||
| Date: May 7, 2026 | By: | /s/ Mark Strobeck | ||||||
| Mark Strobeck | ||||||||
| Chief Executive Officer | ||||||||
